Company: PFSA
Filing Date: 2025-04-03
Form Type: S-4/A
Source: 0001213900-25-028544
Chunk: 286

Company: Profusa, Inc.
Filing Date: 2025-04-03
Form: S-4/A
Chunk 286
---
 that Profusa will receive all regulatory approvals as and when expected that product launches will occur as and when expected that adequate funding and personnel will be available as and when needed, and that no events outside management’s current plans will occur, such as the introduction of superior or more competitive alternatives to Profusa’s anticipated product, or, for example, the occurrence of significant macroeconomic downturns. Profusa reports its financial results in accordance with GAAP. However, in the view of Profusa’s management, non -GAAPmeasures, such as earnings before interest, taxes, depreciation and amortization (“EBITDA”), and net cash flow, provide meaningful insight into Profusa’s performance and a supplemental perspective of its results of operations. Profusa calculates EBITDA as net income (loss), adjusted to exclude: (1) taxes (2) interest expense, and (3) depreciation and amortization. Profusa calculates net cash flow as net income (loss), adjusted to exclude: (1) taxes (2) interest expense, (3) depreciation and amortization, and (4) capital expenditure. Therefore, these non -GAAPmeasures have been forecasted and included in the financial projections. EBITDA is most closely related to the GAAP measure of net income or loss, however EBITDA excludes expenses related to interest, taxes, depreciation and amortization. Net cash flow is most closely related to the GAAP measure of net income or loss, however net cash flow excludes non -cashexpenses and further adjusts for changes in working capital. These non -GAAPmeasures are commonly utilized by business managers and the investors. The financial projections for revenue, EBITDA, net cash flow, capital expenditures and working capital investment and Profusa’s projected commercial development timeline constitute forward -lookingstatements that were based on growth assumptions that are inherently subject to significant uncertainties and contingencies, many of which are beyond Profusa’s control. All projections are innately and necessarily speculative, and Profusa management believes that the prospective financial information in this section covering periods beyond including and beyond 2022 carries high levels of uncertainty and should be read in that context. Because of these assumptions and uncertainties, Profusa anticipates that there is a possibility that the actual results will be materially different from those contained in the projections, including the potential to be materially lower. The inclusion of the projections and anticipated timeline in this proxy statement/prospectus should not be regarded as an indication that NorthView, Profusa, its management, Board of Directors, or its